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ABSTRACT Nuclear extracts from pre-B and B cell lines
contain a nuclear DNA binding protein (K locus protein, KLP)
that specifically recognizes a DNA sequence in the immuno-
globulin K light chain joining (J) segment gene region. KLP is
not observed in mature B cells, T cells, or nonlymphoid cell
types. Two tandem binding sites for KLP designated KI and
KH have been identified by methylation interference analysis to
be immediately proximal to the Ji nonamer-heptamer rec-
ognition sequences and separated by 38 base pairs from each
other. Fragments ofDNA containing KI and KU sites compete
for binding to KLP, and both protein-DNA complexes have the
same electrophoretic mobility. Other flanking sequences of
immunoglobulin gene fragments do not bind to KLP. The
position ofKLP-DNA binding and its tissue-specific expression
suggest that it may be involved in the regulation of lymphoid
gene DNA rearrangements by targeting recombinase to the
K-chain gene region.
The functional diversity of both Ig and the T-cell receptor
(TCR) genes is generated in part by DNA rearrangement
events occurring during the maturation of B and T cells (1-3).
The six known Ig and TCR gene families undergo assembly
of their variable region (V) gene portions from V, joining
region (J), and sometimes diversity region (D) gene elements.
The DNA rearrangements of these six gene families have a
lineage specificity, being generally restricted to either the B-
or the T-cell compartments. In addition, the individual gene
families rearrange at specific points during the differentiation
of the lymphoid cell lineages. In spite of these specificities,
the gene fragments of these six families have highly con-
served flanking nonamer-heptamer DNA sequence elements
that are presumed to mediate the site-specific recombination
events at their borders (1-5). The only obvious DNA se-
quence specificity to these joining signals is the spacing
between the heptamer and nonamer-in all cases, an element
with an approximately 12-base-pair (bp) spacer joins to one
with an approximately 23-bp spacer (4). It seems unlikely that
a set of unique enzymes, each with the complex strand
cleavage and rejoining reactions ofthe recombinase function,
would be synthesized for the independent rearrangement
events of each gene family. A more likely possibility is the
targeting of a common recombinase function to an Ig or TCR
gene-segment site by increased accessibility of a locus by
transcription there (6, 7) or by the action of a specific
activating protein.
In attempting to understand the molecular mechanisms of
activation of these gene families for rearrangement, we
speculated that DNA binding proteins that either recognize
heptamer-nonamer sequences, enhancers, or other cis-act-
ing elements in the gene regions might be involved. In this
paper we characterize a B cell-specific DNA binding protein
that binds to two adjacent DNA sequences that flank the JK
gene segment cluster but are distinct from the heptamer and
nonamer elements. The binding of this nuclear protein may
direct the rearrangement of the K-chain gene family in both a
lineage- and stage-specific manner.
MATERIALS AND METHODS
Nuclear Extracts. Nuclear extracts were prepared from
tissue culture cells by using the protocol of Dignam et al. (8),
yielding protein concentrations of 6-12 mg/ml.
Gel Binding Analysis and Competition Assays. Restriction
fragments from the mouse JK genomic region were prepared
from plasmid subclones of J. segment regions (9). End-
labeled restriction fragments were as follows: KI, containing
JK1 was a 130-bp HindIII-Hinfl fragment; KII, 5' to JK1 and
the KI fragment, was an 83-bp Dde I-HindIII fragment; KIII,
containing JK4, was a 158-bp Ava I-Rsa I fragment. Fig. lA
shows the relative positions of KI, KII, and KIII in the JK
region.
Protein-DNA binding reactions were conducted in 10 mM
Tris chloride, pH 7.5/40 mM NaCl/1 mM EDTA/1 mM
2-mercaptoethanol containing poly[d(I-C)] nonspecific carri-
er DNA, 32P-labeled restriction fragment (0.1-0.5 ng), nucle-
ar extract, 0.1% Triton X-100, and 4% (vol/vol) glycerol for
15 min at room temperature. Poly[d(I-C)] concentrations and
nuclear extract concentrations were titrated against each
other; typically, 0.5-5 Ag poly[d(I-C)] was used with 5-15 ,g
of nuclear extract. Low-ionic-strength polyacrylamide gels
were prepared and run according to previously published
methods (13). For competition assays, various amounts of
purified specific and nonspecific restriction fragments were
added before the nuclear extract to otherwise complete
reaction mixtures described above.
Methylation Interference Assays. Radiolabeled KI, KII, or
KIII fragments (5'-32P-end-labeled on one strand only) were
partially methylated with dimethyl sulfate by standard pro-
cedures (14) to give an average of one methylated guanine
residue per strand. The modified KI, KII, or KIll fragments
were then incubated with PD31 nuclear extract, and the
protein-DNA complexes were isolated on preparative mo-
bility shift gels. Complexed DNA (complex) and uncom-
plexed DNA (free) fractions were cut out of the gel,
electroeluted onto DEAE-paper (NA45, Schleicher &
Schuell), extracted with phenol, precipitated with ethanol,
and treated with 1 M piperidine at 90°C for 30 min. These
samples were lyophilized to dryness twice, resuspended in
98% formamide with bromophenol blue and xylene cylanol
FF dyes, and subsequently fractionated by electrophoresis
through a 7% polyacrylamide/8 M urea gel prior to autoradi-
ography.
Abbreviations: TCR, T-cell receptor; V, variable region; C, constant
region; D, diversity region; J, joining region; KLP, K locus protein;
Ab-MuLV, Abelson murine leukemia virus; H, heavy.
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FIG. 1. The K-chain gene-rearrangement locus and DNA binding
proteins. (A) The orientation and distribution of the three K-chain
gene elements [VK, JK, and constant region (C,)] are shown with the
flanking recombination heptamer (>) and nonamer (P.) sequences.
Both deletional and inversional mechanisms ofDNA rearrangements
of VK + JK are allowed; thus, both orientations of VK are shown, even
though the VK andJK regions are unlinked. The positions of restriction
fragments KI (130 bp), KII (87 bp), and KIII (158 bp) that form
protein-DNA complexes in the electrophoretic mobility-shift assay
are shown. (B and C) Electrophoretic mobility shift assay of nuclear
extracts from B-cell, T-cell, and nonlymphoid-cell lines with radio-
labeled KI (B) or KII (C) DNA fragments. Nuclear extracts were
prepared as described by Dignam et al. (8). In the mobility-shift gel
assay, the DNA fragments were analyzed with 10 Ag of nuclear
extract and 3 ,ug of poly[d(I-C)J in the binding reaction. Cell lines in
lanes: 1, PCC4; 2, BAF3 (10); 3, HAFTL (11); 4, 38B9; 5, PD31; 6,
AJ9; 7, EW; 8, SP2/0; 9, EL4; 10, RLM11; 11, W7; 12, BW5147; 13,
MEL; 14, COS-7; 15, NIH 3T3. The cell lines in lanes 3-8 are in the
B-cell lineage, and the cell lines in lanes 9-12 are in the T-cell lineage;
see the text and Staudt et al. (12) for further descriptions. The
position of the specific protein-DNA complex is designated by an
arrow.
RESULTS
Ig K light chain V regions are assembled by a single joining
event in which a VK gene fragment is recombined with one of
the five JK gene elements tandemly positioned in a 1.4-
kilobase (kb) cluster proximal to the CK exon region (Fig. 1A).
A nuclear extract was prepared from PD31 cells, an Abelson
murine leukemia virus (Ab-MuLV) virus-transformed pre-B-
cell line, to test for DNA binding proteins that might
recognize sequences within the VK, region. PD31 cells in
culture are able to rearrange their endogenous K-chain alleles
as well as exogenously added substrates for K-chain gene
rearrangement (9, 15). Small restriction fragments from
cloned J,. cluster DNA were analyzed for specific protein-
DNA complexes by an electrophoretic mobility-shift assay
(13). In this assay, a nuclear extract is mixed with a labeled
DNA fragment and a large excess of unlabeled poly[d(IC)],
and DNA-protein complexes are resolved from free DNA by
electrophoresis. By using this assay, two DNA fragments
(designated KI and KII, Fig. 1A), that included the Jj1 gene
segment, its nonamer-spacer-heptamer recognition se-
quences, and its 5' proximal sequences, were observed to
bind to a PD31 nuclear protein that we designate KLP for K
locus protein (bands KI and KII in lanes 5 of Fig. 1 B and C).
We explored what cell lines contain KLP, concentrating on
lines representing different stages of the B-cell and T-cell
lineages. The B-cell lineage is usefully separated into several
differentiation stages identified by the configuration of their
Ig-related DNA. Pre-B-cells of different configuration can be
isolated by the transformation of progenitor cells with Ab-
MuLV, Harvey murine sarcoma virus, or by growth in the
presence of interleukin 3 (10, 11, 16). Certain lymphomas
represent B cells (surface Ig-positive), and myelomas or
hybridomas represent more mature plasma cells (secreting
immunoglobulin). Cells like the BaF3 cell line are presumed
to be a progenitor cell of the B-cell lineage because they are
able to repopulate the B-cell compartment of irradiated mice
and contain no Ig rearrangements (10). BaF3 nuclear extracts
were negative for KLP by our assay (Fig. 1 B and C, lane 2).
The Harvey murine sarcoma virus-transformed line, HAFTL,
contains primarily germ-line configuration of Ig heavy and
light chain genes but frequently undergoes the initial D-to-J
Ig heavy chain rearrangement in culture (ref. 14; A. Ales-
sandrini, J. Pierce, S. Desiderio, and D.B., unpublished
data). HAFTL was observed to have the KLP binding
activity with both the KI and KII restriction fragments (lane
3), even though K-chain gene rearrangement has not been
demonstrated in this line. Ab-MuLV-transformed later-stage
pre-B-cell lines 38B9 and PD31 (Fig. 1 B and C, lanes 4 and
5) and Ed2-2 and 18-81-2 (data not shown) contained KLP in
their nuclear extracts. 38B9 cells did not rearrange endoge-
nous K-chain genes despite the presence of KLP. All of the
nuclear extracts from later nonsecreting stages of the B-cell
lineage were positive forKLP by this assay [pre-B- and B-cell
stages (Fig. 1, lanes 3-7) and WEHI-231, 70Z, 230-37, Raji,
710C, M1241, and MRL39 nuclear extracts (data not shown)].
Both the KI and KII restriction fragments produced the same
pattern (Fig. 1 B and C). In contrast, nuclear extracts from
plasma cell tumor lines [SP2/0 (Fig. 1, lane 8) and MPC-11,
KR12, 8826, and S107 (data not shown)] were negative or
very weakly positive for KLP. Thus, production of KLP is
restricted to the nonsecreting stages of the B-cell compart-
ment. The Epstein-Barr virus-transformed human cell lines
EW (Fig. 1 B and C, lane 7), Raji, and 710C have a reduced
level of the DNA binding protein compared with equivalent
amounts of nuclear extract protein of several mouse B-cell
lines (see the Discussion). Minor complexes of KI and KII
with other proteins were generally not tissue-specific and
were not further characterized (Fig. 1 B and C).
When nuclear extracts were prepared from T-lymphoid-
lineage cells or nonlymphoid cells, no KLP complex was
detected similar to that produced by PD31 extracts. Nuclear
extracts from the T-cell lineage (BW5147, RLM11, EL4, or
W7), embryonic precursor cell types (PCC4 or C5), or
nonlymphoid differentiated cells (NIH 3T3, HeLa, COS-7,
B104 retinoblastoma, or MEL cells) did not form the char-
acteristic specific DNA-protein complex with either the KI
or KII restriction fragment (Fig. 1 B and C and data not
shown).
We suspected that the KI and KII restriction fragments
were binding to the same protein because of the identical
tissue specificity of both protein-DNA complexes. A com-
A
B
VK JK 1
KII KI
1 2 3 4 5 6 7
_t i_*t
A~~~~~. A AaA
Kl-
Kl1-
Biochemistry: Weaver and Baltimore
.M
1518 Biochemistry: Weaver and Baltimore
petition assay between the KI and KII fragments for binding
to KLP was conducted by using the mobility shift assay (12,
17). Radiolabeled KII restriction fragment (0.1 ng) was mixed
with increasing quantities of unlabeled KII fragment, KI
fragment, or an unrelated restriction fragment from pBR322
of similar size, and the retention of the protein-DNA com-
plex was assessed by the mobility-shift assay. The KI and KII
fragments (5-50 ng) were both able to compete for the protein
binding as demonstrated by the decrease in specific 32p_
labeled KII-protein complex with the addition of increasing
quantities of these restriction fragments (Fig. 2A). In con-
trast, a nonspecific restriction fragment from pBR322 (5-50
ng) was unable to compete with the specific fragment for
complex formation (Fig. 2A). With radiolabeled KI, a similar
competition result was observed with either KI or KII
fragment (data not shown). After adjustment for molar
amounts of KI and KII fragments, it appeared that KII
competed about 2 times better than KI at a similar concen-
tration for binding of end-labeled KII fragment. In the
reciprocal competition for radiolabeled KI binding, KII
competed slightly better than the KI fragment. The experi-
ence of our laboratory indicates that the specific mobility of
the protein-DNA complex in this assay is mostly determined
by the protein when small DNA restriction fragments are
used. A comparison of adjacent lanes showed virtual
comigration of the KLP complexes formed with the KI and
KII restriction fragments in spite of the DNA size difference
of 43 bp (Fig. 2B). The competition assay and the electro-
phoretic mobility of the complexes thus suggest that KI and
KII bind the same nuclear protein, KLP.
We analyzed the guanine contact residues of the specific
KLP-DNA complexes by a methylation interference assay.
Fragments KI or KII, 5'-end-labeled on one strand, were
partially methylated with dimethyl sulfate and subsequently
incubated with PD31 nuclear extract. The protein-DNA
complexes with KI and KII and the unbound fragments were
isolated from a preparative mobility-shift gel, cleaved with
piperidine, and fractionated on a denaturing DNA sequencing
gel (12, 14, 17). The complexed DNA from the two strands of
the KII fragment (Fig. 3 A and B, lanes labeled Complex) and
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FIG. 2. Competition assay of KI and KII sites for nuclear protein
binding. (A) Radiolabeled KII fragment (0.1 ng; 5000 cpm) was put
in competition with increasing amounts (5-50 ng) of unlabeled 87-bp
KII fragment (KII), 130-bp KI fragment (KI), or 142-bp pBR322
Hinfl restriction fragment (pBR Hinf) for binding to PD31 nuclear
extract protein (10 ,ug) in the presence of 3 /ig of poly[d(I.C)] as
described. A mobility-shift gel assay was conducted to determine the
stability of the complexes in the presence of a DNA competitor. (B)
Mobility-shift assay of radiolabeled KI or KII fragments complexed
with PD31 nuclear extract and fractionated in adjacent lanes.
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FIG. 3. Methylation interference mapping of nuclear protein
binding to KI and KII sites. Radiolabeled KI and KII fragments were
partially methylated and then used in the protein-DNA binding
reactions with PD31 nuclear extracts. Complexed DNA (lanes
labeled Complex) and uncomplexed DNA (lanes labeled Free)
fractions were excised and electroeluted from the gel, treated with
piperidine (14), and fractionated on a DNA sequencing gel. The
partially methylated KI or KII fragment without treatment with
nuclear extract (lanes G) was also fractionated. (A) KII coding
strand. (B) KII noncoding strand. (C) KI coding strand. (D) KI
noncoding strand. Arrows designate guanine residues that are of
reduced intensity or absent in complexed DNA relative to unbound
DNA.
KI fragment (Fig. 3 C and D, lanes labeled Complex) was
deficient in DNA modified at the specific guanine residues
indicated by arrows. In contrast, the partial methylation
pattern of the uncomplexed fragment (Fig. 3, lanes labeled
Free) was the same as the methylated fragment not treated
with a nuclear extract (Fig. 3, lanes G). The same binding
region was localized by using other pre-B-cell nuclear ex-
tracts from 38B9 and 18-81-2 cells (data not shown).
The methylation interference assay delineated two binding
sites that were 5' to the JK nonamer-heptamer elements and
separated by 38 nucleotides (Fig. 4A). Site KI has five
guanine residue contacts on the coding strand and two
guanine residue contacts on the noncoding strand, forming a
binding site of 16 bp with a 10-bp inverted repeat symmetry.
Similarly, the site KII consists of two guanine residue
contacts on the coding strand and three guanine residue
contacts on the noncoding strand, forming a 16-bp binding
site with a 14-bp imperfect inverted repeat symmetry. Meth-
ylation of a guanine residue 2 nucleotides further 5' to KI
partially interfered with binding but was not included in the
postulated binding site because it fell outside the inverted
repeat. Two guanine residues internal to KI (noncoding
strand) and four guanine residues internal to KII (coding and
noncoding strands) did not interfere with binding when
methylated. Thus, both KI and KII have a similar asymmet-
ric KLP binding motif in the same orientation in the J.4 locus
on both the coding and noncoding strands (Fig. 4A). KI and
Proc. Natl. Acad. Sci. USA 84 (1987)
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nuclear extract and found no stable protein-DNA complexes
Ki JK1 under our conditions (data not shown). Thus, we consistently
TCCTCTTCAGTGAGGA failed to observe DNA binding protein complexes in associ-
-38 - GAAGTCACT 2 3 ation directly with nonamer-spacer-heptamer sequences,
zcCthe proposed site for recombinase action.
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FIG. 4. KI, KIT, and KIll binding sites for nuclear proteins in
PD31 extract. (A) The KLP binding sites KI and KII. Using the
methylation interference methodology (Fig. 3), two binding sites of
KLP were identified. The KI and KIT sites were separated by 38 bp
and immediately flanked the JK nonamer-heptamer sequence in the
K-chain gene region. Those guanine residues whose methylation
interfered with binding are marked with a superior or inferior circle.
Both sites have inverted repeat symmetry designated by bold arrows.
The top strand is the coding strand (Fig. 3A and C); the bottom strand
is the noncoding strand (Fig. 3 B and D). (B) Methylation interference
analysis of a ubiquitous nuclear protein binding to the site KIll in the
K-chain gene region. A preparative mobility shift gel was used to
isolate a complex of KIII (JK4) with a different nuclear protein from
KLP, as in Fig. 2 and the text.
KII shared a conserved DNA sequence at the external arms
of both inverted repeats and a conserved spacer length of 10
intervening nucleotides separating them (TCC-NOGGA).
The conservation of nucleotides and spacing ofresidues in KI
and KII also suggests that they bind the same B-cell nuclear
protein. The structure of the KLP binding site is reminiscent
of the structure of the nuclear factor I DNA binding site,
which consists of an inverted repeat and conserved spacing
(TGGN7CCA) (18).
A third complex, KIII, was observed by testihg a 158-bp
Rsa I-Ava I restriction fragment containing 105 bp of 5'
flanking sequences, nonamer-23-bp spacer-heptamer, and
13 bp of JK4 DNA (Fig. 1A). The KIII complex was detected
in every nuclear extract tested, including B-, T-, and non-
lymphoid-cell types and was readily distinguishable from KI
and KII complexes because it had a lower mobility. The
methylation interference assay on the noncoding strand
indicated that four guanine residues are significant to the
binding site for KIII (Fig. 4B). Although the KIII motif was
mapped to the same relative position ofJK4 as KI was for JK1,
this may not have any functional relevance for the K-chain
gene region. The KIII DNA sequence is not repeated up-
stream of JK4 nor is it conserved between mouse and human.
Other small restriction fragments from the JK cluster formed
protein-DNA complexes in the assay, but only at a reduced
intensity, and have not been considered further in this study.
We considered the possibility that other rearrangement
sites such as the Ig D regions, heavy (H) chain VH, VK, or
other J gene elements would similarly have recognition sites
for binding proteins flanking the nonamer-heptamer se-
quences. A fourth complex, DI, was observed with a 107-bp
Hinfl-Sac I restriction fragment containing the DQ52 ele-
ment and the two sets of flanking nonamer-12-bp spacer-
heptamer DNA sequences on either border. However, like
KIII, DI was observed in all nuclear extracts tested (data not
shown). Whereas KI and KII complexes had the same
mobility in the electrophoretic assay, complexes with KIII
and DI had different mobilities from each other and from
complexes with KI or KIT. There was no significant
protein-DNA complex formation for a restriction fragment
containing the VK21 variable gene element, heptamer,
nonamer, and 100 bp of flanking sequence (data not shown).
We tested JH1, JK2, JK3, and VH restriction fragments
containing 50-100 bp of flanking sequences on the border of
their nonamer-23-bp spacer-heptamer motifs with PD31
DISCUSSION
A B cell-specific nuclear protein (KLP) binds to DNA in a
K-chain gene region proximal to the JK1 element. Two DNA
binding sites, each composed of imperfect inverted repeats
and separated by 38 bp, form a common binding motif. These
data, in conjunction with competition assays and the identical
mobility of the protein-DNA complexes, suggest that the
same DNA binding protein is capable of interacting with
either site KI or KI.
It is intriguing that KLP is found exclusively in cells of the
B-cell type and specifically in the immature stages represent-
ed by pre-B- and B-cell lines. K-Chain gene rearrangement
occurs at the pre-B-cell stage and has been observed in tissue
culture in several pre-B-cell lines transformed by Ab-MuLV
(9). KLP may be directly involved in the K-chain gene
rearrangement process, possibly by targeting a common
recombinase enzyme to the site proximal to JK1. The pres-
ence of KLP alone is insufficient to activate K-chain gene
rearrangement because the HAFTL and 38B9 cell lines,
which rearrange Ig heavy chain genes but not endogenous
K-chain genes, contained KLP. However, the process of
DNA rearrangement is likely to be a complex event involving
multiple nuclear proteins; thus, it would not be surprising if
the presence of a single nuclear protein does not exclusively
determine the appropriate regulation of rearrangement.
Alternatively, KLP may be a regulatory protein that prevents
K-chain gene rearrangement until u-chain gene rearrange-
ment has been successfully completed. A transcription model
for the specificity of gene rearrangement has also been
proposed whereby the accessibility of DNA sequences to
recombination is stimulated by local transcription events (6,
7). Possibly KLP functions as a transcription factor whose
activity identifies the K locus for rearrangement. It is unlikely
that KLP functions as a transcription factor for expression of
K-chain protein because the KI and KII sites are usually
deleted in K-chain gene rearrangements, and KLP is absent in
mature B-cell stages, where K-chain transcription is maximal.
Also, we have not found an induction of KLP in 70Z cells
treated with lipopolysaccharide or cycloheximide, conditions
that activate K-chain genes for transcription and increase the
abundance oftwo K-chain gene enhancer or promoter binding
proteins, NF-KB and NF-A2 (12, 17). Possibly other Ig or
T-cell gene families have similar proteins that may direct
recombinase to a different region, activating an alternative
timing and stage-specific rearrangement or generating other
functions such as Ig H chain gene isotype switching.
Of the five JK elements, JK1 is the most frequently utilized
in rearrangement events to VK, as demonstrated in primary B
cells by DNA and nuclear RNA mapping (19, 20). The
proximity of the KI and KII sites to the nonamer-spacer-
heptamer of the JK1 gene element and thus to the site of KLP
binding may explain why JK1 is the most frequently rear-
ranged.
There is a significant DNA sequence homology flanking the
JKl gene elements of the mouse, rat, and human for approx-
imately 100 nucleotides upstream. Although the rat KI and
KII DNA sequences are identical to those of the mouse, the
human KI and KII sequences differ from them by one residue
(human DNA KI site = TCCTCTTCAGTGAGAA, with
asterisk over the distinctive residue). This may explain why
human B-cell extracts apparently have lower levels of the
KLP complex than do mouse nuclear extracts with the mouse
Biochemistry: Weaver and Baltimore
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KI and KII DNA sequences. In addition, the conservation of
the DNA sequence in front of the JKl element of mouse and
human is greater than conservation between the species of
the analogous regions in front of the other most similar JK
elements;
We did not observe a DNA binding protein in association
with the JH1 region in the analogous position to JK1. Possibly
other parameters such as the number of rearrangement steps
or the distance between V and J elements also may be
relevant to the regulation of the rearrangement process.
Because every Ig and TCR gene family contains its own
unique gene element structural organization, they also may
utilize unique mechanisms for activation of each family for
gene rearrangement.
Recombination enhancers have been observed for the
site-specific inversion of genes encoding bacteriophage or
Salmonella surface antigens (21) or yeast mating-type switch-
ing. Site-specific inversion of Salmonella surface antigen
genes requires the binding of a host protein to a sequence
flanking the inverted repeat elements where the breakage and
rejoining of the phase-variation inversion occurs (22). This
cis-acting regulatory sequence is defined as a recombination-
al enhancer element in that it functions in an orientation- and
distance-independent manner. KLP may serve a similar
function for aligning the Ig and TCR recombinase.
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